An expandable fusion cage system includes an expandable fusion cage having an upper portion, a lower portion, and a hinge portion coupling the lower portion and the upper portion at their distal ends. Positioned between the upper and lower portions is an expansion element that when moved in the proximal direction causes the cage to expand at its proximal end. The system can also include inserter instruments, expandable distraction instruments, and bone funnels.

A spiral blood flow device includes a stent made up of a plurality of expansion members joined to a plurality of axial members that permit the stent to change diameter among a continuum of expanded configurations. The axial members have fixed orientation, whereas the expansion members have a variable orientation relative to the longitudinal axis throughout the continuum of expanded configurations. A spiral flow inducing structure, which may include fins attached to the axial members, define a helical flow angle that remains constant throughout the continuum of expanded configurations.

Provided is a coated implantable medical device, comprising: a substrate; and a coating disposed on said substrate, wherein said coating comprises at least one polymer and at least one pharmaceutical agent in a therapeutically desirable morphology and/or at least one active biological agent and optionally, one or more pharmaceutical carrying agents; wherein substantially all of pharmaceutical agent and/or active biological agent remains within said coating and on said substrate until the implantable device is deployed at an intervention site inside the body of a subject and wherein upon deployment of said medical device in the body of said subject a portion of said pharmaceutical agent and/or active biological agent is delivered at said intervention site along with at least a portion of said polymer and/or a at least a portion of said pharmaceutical carrying agents.

Prosthetic heart valves each includes a link extending along an axial direction and an axial frame. The axial frame includes a plurality of struts comprising a plurality of inner struts pivotally attached to a plurality of outer struts at a plurality of pivot nodes. A first pivot node of the plurality of pivot can be attached to the link and a second pivot node of the plurality of pivot nodes can move relative to the link in the axial direction. Methods of radially expanding a prosthetic heart valve can comprise radially expanding the radially expandable frame from a radially retracted orientation to a radially expanded orientation while the second pivot node axially translates relative to the link.

An eye and eyelid cover includes a pair of spaced viewing windows between which, in use, a reservoir of hot water is contained, and a compartment within which a phase change material is contained, the phase change material being molten at the initial temperature of the hot water and solidifying during cooling of the hot water while a treatment procedure is being carried out.

A tapered implantable device includes an ePTFE tubular member having a tapered length portion. The tapered length portion provides rapid recovery properties. The tapered length portion can feature a microstructure that includes a multiplicity of bent fibrils.

There is provided herein a breast implant comprising: an internal skeleton element comprising a base configured to face a subject's chest wall when implanted, a dome configured to face a subject's nipple-areola complex when implanted, and a projecting structure extending between the base and the dome; and a shell enclosing the internal skeleton element and filled with a filler substance. The breast implant is configured to be inserted into a sub-glandular plane, a sub-muscular plane or a subcutaneous plane of a subject's breast, to affect the projection and volume of the breast.

The present disclosure relates to techniques for restricting urethra. More specifically, a constriction device is provided, having one or several constriction elements configured to be inflated and thereby expand in a first direction towards the urethra to constrict a first portion of the urethra for restricting the flow of fluid therethrough.

Prosthetic valve devices for implantation within a body or lumen that are configured for hemodynamic monitoring. The prosthetic valve device includes one or more sensors in electrical communication with an inductor formed by a portion of the frame or coupled to the frame of the prosthetic valve device. The sensor is configured to measure a flow parameter within the prosthesis. The inductor is configured to relay a signal to an external detector, the signal being associated with the flow parameter measured by the sensor.

A void occlusion device that includes a scaffold defining a plurality of voids and a reinforcement member is described. The scaffold is configured to permit the infiltration of human tissue into the plurality of voids. The reinforcement member extends through at least a portion of the scaffold and is configured to resist compressive forces exerted on the scaffold. Also described are embodiments where the void occlusion device is biocompatible, bioresorbable, elastic, and suitable for radio imaging.